Anacor sets IPO range

Anacor Pharmaceuticals Inc. (Palo Alto, Calif.) amended its IPO and hopes to sell 4.7 million shares at $16-$18 in an offering underwritten by Citigroup; Deutsche Bank; Cowen; and Wedbush. A $17 price would raise $80 million and value the company at $294.3 million. In September, the company refiled to raise up to $86.3 million. In 2008, Anacor withdrew an IPO for up to $57.5 million, citing market conditions. ...